Loading
Junji Gene
Founded in 2021, GentleGen is a company dedicated to promoting the development of life science engineering through the research and development of life science robots combined with the application of artificial intelligence in life science. The company has established oligonucleotide synthesis, Sanger sequencing, gene synthesis, protein antibody service platform and intelligent production workshop. GentleGen has independently designed and developed multiple scene equipment and production lines.
Funding
Every round, secondary, debt facility or acquisition involving Junji Gene that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—